92.7
Enliven Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
77.8
FY23:
266
FY24:
318
FY25:
475
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.95
FY22:
5.55
FY23:
5.72
FY24:
7.63
FY25:
1.29
Total assets
Change from FY21 to FY25
millions USD
FY21:
93.6
FY22:
83.3
FY23:
272
FY24:
326
FY25:
476
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
7.21
FY22:
9.72
FY23:
25.9
FY24:
15.9
FY25:
16.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.41
FY22:
0.66
FY23:
0.07
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
86.0
FY22:
−76.8
FY23:
246
FY24:
310
FY25:
460
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
93.6
FY22:
–
FY23:
272
FY24:
326
FY25:
476
All amounts in millions USD